Novo Nordisk: Novo Nordisk Foundation expands Challenge Programme outside of Denmark for the first time and significantly increases grants
COPENHAGEN, Denmark, April 29, 2025 /PRNewswire/ -- The Novo Nordisk Foundation today announced the latest edition of its annual Challenge Programme, where for the first time it is inviting resear...
Read full article »
Novo Nordisk is a Denmark-based multinational pharmaceutical company that develops and commercializes diabetes care medications and devices for the healthcare industry.
Read more